Telecom Healthcare Sector

Gyre Therapeutics

Market Cap: US$919.5m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

InMode

Market Cap: US$919.1m

Designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.

Wave Life Sciences

Market Cap: US$917.1m

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Nutex Health

Market Cap: US$908.8m

Operates as a physician-led, healthcare services, and operations company in the United States.

Spyre Therapeutics

Market Cap: US$904.7m

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Evolent Health

Market Cap: US$892.1m

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

Avadel Pharmaceuticals

Market Cap: US$883.2m

Operates as a biopharmaceutical company in the United States.

Extendicare

Market Cap: CA$1.2b

Through its subsidiaries, provides care and services for seniors in Canada.

Nanosonics

Market Cap: AU$1.3b

Operates as an infection prevention company globally.

Pharvaris

Market Cap: US$863.2m

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Syndax Pharmaceuticals

Market Cap: US$854.5m

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

HealthStream

Market Cap: US$851.7m

Provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States.

uniQure

Market Cap: US$848.6m

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

CorMedix

Market Cap: US$838.3m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Niagen Bioscience

Market Cap: US$836.7m

Operates as a bioscience company engages in developing healthy aging products.

LENZ Therapeutics

Market Cap: US$827.5m

Operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.

AMN Healthcare Services

Market Cap: US$822.4m

Provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States.

Enliven Therapeutics

Market Cap: US$784.6m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

SI-BONE

Market Cap: US$783.3m

A medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

Zymeworks

Market Cap: US$781.8m

A clinical-stage biotechnology company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer, and autoimmune and inflammatory diseases (AIID).

Cronos Group

Market Cap: CA$1.1b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Xeris Biopharma Holdings

Market Cap: US$773.5m

A commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois.

Akebia Therapeutics

Market Cap: US$766.9m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Nuvation Bio

Market Cap: US$762.2m

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

WELL Health Technologies

Market Cap: CA$1.0b

Operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.

Immunome

Market Cap: US$748.3m

A clinical-stage biotechnology company, develops targeted cancer therapies.

Nurix Therapeutics

Market Cap: US$741.0m

A clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.

Praxis Precision Medicines

Market Cap: US$735.3m

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance.

Veradigm

Market Cap: US$721.8m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

ArriVent BioPharma

Market Cap: US$697.9m

A clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

GH Research

Market Cap: US$692.9m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Akso Health Group

Market Cap: US$692.0m

Operates a social e-commerce mobile platform in the People’s Republic of China.

Rocket Pharmaceuticals

Market Cap: US$675.5m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

Curaleaf Holdings

Market Cap: CA$931.5m

Produces and distributes cannabis products in the United States and internationally.

Nika Pharmaceuticals

Market Cap: US$667.0m

A pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases.

Arbutus Biopharma

Market Cap: US$660.8m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.